Cytokinetics Inc (CYTK) income statement
CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$50.78−0.68 (-1.32%)
Close on Nov 20, 2026Market cap $7.06BP/E –Yield –
Cytokinetics Inc financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $7.06BP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||||||||||
| Operating margin | -695.4% | -2,902.7% | -6,589.7% | -342.8% | -264.5% | -168.3% | -368.0% | -282.3% | -848.3% | 17.6% | -130.5% | -31.4% | -110.6% | -535.2% | -1,199.1% | -1,926.1% | 32.0% | – | – | – |
| EBITDA margin | -683.9% | -2,851.1% | -6,431.8% | -336.6% | -261.3% | -165.0% | -363.2% | -278.3% | -833.9% | 18.3% | -128.5% | -30.4% | -109.2% | -527.4% | -1,166.7% | -1,852.3% | 34.5% | – | – | – |
| Pre-tax margin | – | – | – | – | – | – | – | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | -110.0% | -534.1% | -1,196.5% | -1,919.4% | 30.3% | – | – | – |
| Net profit margin | -891.6% | -3,191.1% | -6,988.6% | -411.2% | -305.7% | -228.0% | -452.9% | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | -110.0% | -534.1% | -1,196.5% | -1,912.6% | 30.1% | – | – | – |
| Free cash flow margin | -607.5% | -2,164.1% | -5,521.2% | -328.6% | -271.8% | -3.8% | -348.1% | -324.1% | -782.7% | 33.3% | 15.1% | -97.9% | -27.0% | -444.0% | -1,150.9% | -1,758.8% | 9.6% | – | – | – |
| Effective tax rate | – | – | – | – | – | – | – | – | – | 0.00% | – | – | – | – | – | – | 0.61% | – | – | – |
| Returns on capital | ||||||||||||||||||||
| Return on equity | 197.5% | 226.0% | 213.0% | -572.1% | -120.5% | -248.5% | -1,622.9% | -156.6% | -125.2% | 20.2% | -46.7% | -20.0% | -54.2% | -70.5% | -85.5% | -57.3% | 32.5% | -75.3% | -47.4% | -53.7% |
| Return on assets | -55.5% | -53.0% | -57.2% | -41.9% | -31.3% | -30.9% | -48.6% | -42.0% | -55.0% | 11.5% | -30.2% | -13.6% | -42.0% | -62.0% | -73.2% | -63.2% | – | – | – | – |
| Return on tangible assets | -55.5% | -53.0% | -57.2% | -41.9% | -31.3% | -30.9% | -48.6% | -42.0% | -55.0% | 11.5% | -30.2% | -13.6% | -42.0% | -62.0% | -73.2% | -63.2% | – | – | – | – |
| Return on invested capital | 34.5% | 38.4% | 42.5% | 42.5% | 43.7% | 25.8% | 42.9% | 51.2% | 97.7% | -54.9% | 303.0% | -131.5% | – | – | – | – | – | – | – | – |
| Return on capital employed | -50.1% | -55.2% | -60.1% | -38.2% | -29.3% | -24.5% | -43.7% | -39.4% | -56.8% | 17.0% | -38.8% | -17.8% | -53.4% | -68.2% | -80.7% | -70.2% | – | – | – | – |
| Return on total capital | 304.1% | 307.8% | 274.9% | -261.3% | -82.7% | -97.0% | -193.0% | -84.7% | -85.3% | 18.0% | -42.7% | -16.0% | – | – | – | – | – | – | – | – |
| NOPAT | -$483.68M | -$423.64M | -$392.00M | -$256.12M | -$147.19M | -$74.21M | -$78.10M | -$70.24M | -$89.58M | $18.69M | -$29.55M | -$11.66M | -$26.78M | -$31.96M | -$37.89M | -$39.21M | $25.94M | – | – | – |
| Cash flow quality | ||||||||||||||||||||
| OCF / Sales | -579.3% | -2,143.0% | -5,502.4% | -316.7% | -202.4% | 16.0% | -338.3% | -321.3% | -761.2% | 34.8% | 17.0% | -95.5% | -25.2% | -442.4% | -1,139.9% | -1,739.6% | 10.3% | – | – | – |
| OCF / Net income | 0.65 | 0.67 | 0.79 | 0.77 | 0.66 | -0.07 | 0.75 | 0.95 | 0.80 | 2.25 | -0.13 | 3.06 | 0.23 | 0.83 | 0.95 | 0.91 | 0.34 | – | – | – |
| FCF / OCF | 104.9% | 101.0% | 100.3% | 103.8% | 134.3% | -23.6% | 102.9% | 100.9% | 102.8% | 95.7% | 88.5% | 102.5% | 107.0% | 100.4% | 101.0% | 101.1% | 93.5% | – | – | – |
| FCF / Net income | 0.68 | 0.68 | 0.79 | 0.80 | 0.89 | 0.02 | 0.77 | 0.96 | 0.82 | 2.15 | -0.12 | 3.14 | 0.24 | 0.83 | 0.96 | 0.92 | 0.32 | – | – | – |
| FCF / EBITDA | 88.8% | 75.9% | 85.8% | 97.6% | 104.0% | 2.3% | 95.9% | 116.5% | 93.9% | 182.1% | -11.7% | 322.1% | 24.7% | 84.2% | 98.7% | 94.9% | 28.0% | – | – | – |
| Unlevered free cash flow | -$498.81M | -$370.01M | -$393.39M | -$295.51M | -$178.41M | $10.50M | -$88.29M | -$99.10M | -$102.25M | $37.52M | $4.53M | -$45.95M | -$8.26M | -$33.56M | -$46.01M | -$45.18M | $7.87M | – | – | – |
| Levered free cash flow | -$534.82M | -$399.80M | -$415.75M | -$310.85M | -$191.39M | -$2.11M | -$93.53M | -$102.10M | -$104.64M | $35.39M | $4.32M | -$45.95M | -$8.26M | -$33.56M | -$46.04M | -$45.32M | $7.87M | – | – | – |
| Efficiency | ||||||||||||||||||||
| Asset turnover | 0.06 | 0.02 | 0.01 | 0.10 | 0.10 | 0.14 | 0.11 | 0.12 | 0.06 | 0.75 | 0.23 | 0.43 | 0.38 | 0.12 | 0.06 | 0.03 | – | – | – | – |
| Fixed asset turnover | 1.21 | 0.27 | 0.10 | 1.23 | 1.63 | 6.25 | 6.95 | 9.30 | 3.71 | 39.50 | 16.92 | 32.85 | 27.64 | 6.55 | 2.20 | 1.11 | – | – | – | – |
| Receivables turnover | 5.12 | 2.06 | 10.53 | 3.64 | 2.50 | 11.65 | 7.27 | 18.85 | 23.54 | 4,433.63 | – | – | – | – | – | – | – | – | – | – |
| Days sales outstanding | 71.3 | 177.2 | 34.7 | 100.3 | 145.7 | 31.3 | 50.2 | 19.4 | 15.5 | 0.1 | – | – | – | – | – | – | – | – | – | – |
| CapEx to revenue | 28.2% | 21.1% | 18.8% | 12.0% | 69.4% | 19.8% | 9.7% | 2.8% | 21.5% | 1.5% | 2.0% | 2.4% | 1.8% | 1.7% | 11.1% | 19.1% | 0.67% | – | – | – |
| CapEx to OCF | -4.9% | -0.99% | -0.34% | -3.8% | -34.3% | 123.6% | -2.9% | -0.88% | -2.8% | 4.3% | 11.5% | -2.5% | -7.0% | -0.37% | -0.97% | -1.1% | 6.5% | – | – | – |
| CapEx to depreciation | 2.45 | 0.41 | 0.12 | 1.95 | 21.47 | 6.04 | 2.03 | 0.72 | 1.50 | 2.15 | 0.95 | 2.25 | 1.25 | 0.21 | 0.34 | 0.26 | 0.27 | – | – | – |
| Liquidity | ||||||||||||||||||||
| Current ratio | 4.53 | 6.17 | 6.12 | 9.40 | 7.45 | 15.20 | 8.98 | 9.36 | 8.45 | 4.77 | 3.57 | 5.50 | 2.97 | 10.76 | 11.14 | 10.04 | – | – | – | – |
| Quick ratio | 4.53 | 6.17 | 6.12 | 9.40 | 7.45 | 15.20 | 8.98 | 9.36 | 8.45 | 4.77 | 3.57 | 5.50 | 2.97 | 10.76 | 11.14 | 10.04 | – | – | – | – |
| Cash ratio | 5.93 | 6.68 | 6.38 | 9.80 | 8.68 | 16.06 | 10.29 | 8.95 | 8.80 | 4.93 | 3.53 | 3.49 | 3.00 | 10.42 | 10.67 | 9.78 | – | – | – | – |
| Working capital | $714.52M | $928.27M | $525.37M | $710.57M | $463.81M | $443.02M | $207.73M | $185.48M | $241.85M | $125.38M | $81.46M | $107.28M | $52.63M | $69.32M | $46.55M | $66.17M | – | – | – | – |
| Net current asset value | -$1.17B | -$429.11M | -$582.59M | -$327.49M | -$61.78M | $53.80M | -$67.00M | $22.43M | $89.33M | $82.85M | $66.46M | $90.23M | $50.59M | $68.96M | $46.55M | $66.02M | – | – | – | – |
| Leverage | ||||||||||||||||||||
| Total debt | $287.57M | $104.75M | $68.46M | $64.77M | $47.37M | $46.21M | $45.05M | $42.41M | $31.78M | $29.88M | $14.64M | $0 | – | – | – | – | – | – | – | – |
| Net debt | -$912.44M | -$1.10B | -$586.94M | -$764.53M | -$576.33M | -$454.79M | -$222.75M | -$156.29M | -$253.62M | -$134.02M | -$96.96M | -$83.20M | – | – | – | – | – | – | – | – |
| Debt / Equity | -0.44 | -0.77 | -0.18 | -0.60 | 0.19 | 0.41 | -4.12 | 1.64 | 0.29 | 0.32 | 0.21 | 0.00 | – | – | – | – | – | – | – | – |
| Debt ratio | 20.2% | 7.5% | 8.3% | 6.4% | 5.6% | 8.7% | 15.5% | 20.1% | 10.8% | 17.6% | 12.7% | 0.00% | – | – | – | – | – | – | – | – |
| Assets to equity | -2.16 | -10.35 | -2.13 | -9.40 | 3.45 | 4.71 | -26.50 | 8.14 | 2.68 | 1.80 | 1.68 | 1.44 | 1.53 | 1.11 | 1.10 | 1.11 | – | – | – | – |
| Long-term debt to assets | 17.3% | 6.7% | 7.1% | 6.3% | 5.6% | 8.7% | 15.5% | 18.8% | 10.8% | 16.1% | 12.7% | 0.00% | – | – | – | – | – | – | – | – |
| Long-term debt to equity | -0.37 | -0.69 | -0.15 | -0.59 | 0.19 | 0.41 | -4.12 | 1.53 | 0.29 | 0.29 | 0.21 | 0.00 | – | – | – | – | – | – | – | – |
| Total debt / Capitalization | -77.3% | -342.0% | -21.5% | -150.2% | 16.3% | 29.0% | 132.1% | 62.1% | 22.4% | 24.1% | 17.6% | 0.00% | – | – | – | – | – | – | – | – |
| Long-term debt / Capitalization | -59.6% | -221.2% | -17.8% | -144.7% | 16.3% | 29.0% | 132.1% | 60.6% | 22.4% | 22.5% | 17.6% | 0.00% | – | – | – | – | – | – | – | – |
| Net debt / EBITDA | 1.52 | 2.08 | 1.21 | 2.40 | 3.13 | 4.94 | 2.28 | 1.78 | 2.28 | -6.90 | 2.63 | 5.83 | – | – | – | – | – | – | – | – |
| Total debt / EBITDA | -0.48 | -0.20 | -0.14 | -0.20 | -0.26 | -0.50 | -0.46 | -0.48 | -0.29 | 1.54 | -0.40 | -0.00 | – | – | – | – | – | – | – | – |
| Cash flow to debt | -177.4% | -377.9% | -605.2% | -462.4% | -300.9% | 19.4% | -201.8% | -238.6% | -320.2% | 123.8% | 33.4% | – | – | – | – | – | – | – | – | – |
| Interest coverage | ||||||||||||||||||||
| EBIT / Interest expense | -13.43 | -14.22 | -17.53 | -16.70 | -11.33 | -5.89 | -14.93 | -23.42 | -37.60 | 6.93 | -139.58 | – | – | -13,485.67 | -1,370.40 | -282.02 | – | – | – | – |
| EBITDA / Interest expense | -13.21 | -13.97 | -17.11 | -16.40 | -11.19 | -5.77 | -14.73 | -23.09 | -36.96 | 7.20 | -137.38 | – | – | -13,288.67 | -1,333.34 | -271.22 | – | – | – | – |
| (EBITDA − CapEx) / Interest expense | -13.76 | -14.07 | -17.16 | -16.98 | -14.17 | -6.46 | -15.13 | -23.33 | -37.92 | 6.61 | -139.48 | – | – | -13,330.33 | -1,346.00 | -274.02 | – | – | – | – |
| Per share | ||||||||||||||||||||
| Revenue per share | 0.72 | 0.16 | 0.07 | 1.00 | 0.83 | 0.79 | 0.45 | 0.58 | 0.25 | 2.62 | 0.72 | 1.21 | 1.00 | 0.32 | 0.32 | 0.23 | 8.44 | – | – | – |
| EPS (basic) | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 | -1.97 | -2.11 | -1.95 | -2.59 | 0.41 | -0.97 | -0.41 | -1.24 | -2.30 | -4.30 | -4.62 | 2.58 | – | – | – |
| EPS (diluted) | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 | -1.97 | -2.11 | -1.95 | -2.59 | 0.39 | -0.97 | -0.41 | -1.24 | -2.30 | -4.30 | -4.62 | 2.52 | – | – | – |
| Book value per share | -5.37 | -1.15 | -3.80 | -1.14 | 2.88 | 1.60 | -0.18 | 0.47 | 2.04 | 2.32 | 1.73 | 2.38 | 1.77 | 2.95 | 3.86 | 6.32 | 10.50 | – | – | – |
| Tangible book value per share | -5.37 | -1.15 | -3.80 | -1.14 | 2.88 | 1.60 | -0.18 | 0.47 | 2.04 | 2.32 | 1.73 | 2.38 | 1.77 | 2.95 | 3.86 | 6.32 | 10.50 | – | – | – |
| Cash per share | 9.76 | 10.15 | 6.45 | 8.74 | 7.35 | 7.05 | 4.53 | 3.63 | 5.29 | 4.03 | 2.82 | 2.15 | 2.61 | 3.12 | 3.92 | 6.42 | 2.65 | – | – | – |
| Operating cash flow per share | -4.15 | -3.35 | -4.08 | -3.16 | -1.68 | 0.13 | -1.54 | -1.85 | -1.89 | 0.91 | 0.12 | -1.16 | -0.25 | -1.41 | -3.65 | -4.02 | 0.87 | – | – | – |
| Free cash flow per share | -4.35 | -3.38 | -4.09 | -3.28 | -2.26 | -0.03 | -1.58 | -1.87 | -1.94 | 0.87 | 0.11 | -1.19 | -0.27 | -1.41 | -3.69 | -4.06 | 0.81 | – | – | – |
| CapEx per share | 0.20 | 0.03 | 0.01 | 0.12 | 0.58 | 0.16 | 0.04 | 0.02 | 0.05 | 0.04 | 0.01 | 0.03 | 0.02 | 0.0053 | 0.04 | 0.04 | 0.06 | – | – | – |
| Valuation at period end | ||||||||||||||||||||
| Market cap | $7.56M | $5.03M | $7.97M | $3.99M | $3.35M | $1.28M | – | $342.80M | $438.98M | $492.28M | $405.39M | $293.24M | $191.77M | $93.99M | $69.39M | $121.14M | – | – | – | – |
| Enterprise value | -$1.12B | -$1.19B | -$485.85M | -$800.13M | -$427.21M | -$363.06M | – | $174.39M | $161.08M | $435.72M | $307.39M | $210.74M | $106.37M | $12.79M | $11.80M | $95.58M | – | – | – | – |
| P/E | – | – | – | – | – | – | – | – | – | 29.9x | – | – | – | – | – | – | – | – | – | – |
| P/S | 0.1x | 0.3x | 1.1x | 0.0x | 0.0x | 0.0x | – | 10.9x | 32.8x | 4.6x | 14.1x | 6.2x | 6.3x | 12.4x | 17.3x | 47.0x | – | – | – | – |
| P/B | -0.0x | -0.0x | -0.0x | -0.0x | 0.0x | 0.0x | – | 13.2x | 4.0x | 5.2x | 5.9x | 3.2x | 3.5x | 1.3x | 1.4x | 1.7x | – | – | – | – |
| P/TBV | -0.0x | -0.0x | -0.0x | -0.0x | 0.0x | 0.0x | – | 13.2x | 4.0x | 5.2x | 5.9x | 3.2x | 3.5x | 1.3x | 1.4x | 1.7x | – | – | – | – |
| P/OCF | -0.0x | -0.0x | -0.0x | -0.0x | -0.0x | 0.1x | – | -3.4x | -4.3x | 13.3x | 83.0x | -6.5x | -24.8x | -2.8x | -1.5x | -2.7x | – | – | – | – |
| P/FCF | – | – | – | – | – | – | – | – | – | 13.9x | 93.8x | – | – | – | – | – | – | – | – | – |
| EV/Sales | -12.7x | -64.4x | -64.5x | -8.5x | -6.1x | -6.5x | – | 5.5x | 12.0x | 4.1x | 10.7x | 4.5x | 3.5x | 1.7x | 3.0x | 37.1x | – | – | – | – |
| EV/EBITDA | 1.9x | 2.3x | 1.0x | 2.5x | 2.3x | 3.9x | – | – | – | 22.4x | – | – | – | – | – | – | – | – | – | – |
| EV/EBIT | 1.8x | 2.2x | 1.0x | 2.5x | 2.3x | 3.9x | – | – | – | 23.3x | – | – | – | – | – | – | – | – | – | – |
| EV/OCF | 2.2x | 3.0x | 1.2x | 2.7x | 3.0x | -40.6x | – | -1.7x | -1.6x | 11.8x | 63.0x | -4.7x | -13.8x | -0.4x | -0.3x | -2.1x | – | – | – | – |
| EV/FCF | 2.1x | 3.0x | 1.2x | 2.6x | 2.2x | 172x | – | – | – | 12.3x | 71.1x | – | – | – | – | – | – | – | – | – |
| Earnings yield | -10,380.1% | -11,714.0% | -6,605.2% | -9,739.1% | -6,423.6% | -9,948.0% | – | -31.0% | -29.1% | 3.3% | -9.3% | -5.0% | -17.6% | -43.0% | -69.0% | -40.7% | – | – | – | – |
| FCF yield | -7,072.3% | -7,944.0% | -5,218.3% | -7,783.4% | -5,710.0% | -164.8% | – | -29.8% | -23.8% | 7.2% | 1.1% | -15.7% | -4.3% | -35.7% | -66.3% | -37.4% | – | – | – | – |
| Shareholder yield | ||||||||||||||||||||
| Debt paydown yield | 142.9% | 172.5% | 0.00% | 1,193.1% | 0.00% | 0.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Cost structure | ||||||||||||||||||||
| R&D to revenue | 472.5% | 1,837.2% | 4,384.1% | 254.6% | 227.1% | 173.7% | 320.5% | 283.0% | 675.5% | 56.3% | 161.9% | 94.6% | 161.3% | 471.5% | 929.6% | 1,475.1% | 48.9% | – | – | – |
| Stock-based comp to revenue | 127.5% | 529.6% | 957.0% | 50.6% | 38.1% | 31.6% | 40.0% | 31.0% | 67.5% | 6.7% | 15.9% | 7.1% | 11.7% | 50.0% | 76.7% | 155.9% | 6.0% | – | – | – |
| Per employee | ||||||||||||||||||||
| Total employees | 673 | 498 | 423 | 409 | 253 | 184 | 156 | 130 | 137 | 127 | 100 | 92 | 85 | 70 | 79 | 105 | 111 | 110 | 161 | 148 |
| Revenue per employee | $130.82K | $37.10K | $17.80K | $231.27K | $278.37K | $303.41K | $172.23K | $242.32K | $97.58K | $837.85K | $286.58K | $510.22K | $360.56K | $107.99K | $50.63K | $24.54K | $734.58K | – | – | – |
| Operating profit per employee | -$909.74K | -$1.08M | -$1.17M | -$792.67K | -$736.42K | -$510.56K | -$633.76K | -$683.97K | -$827.71K | $147.14K | -$374.07K | -$160.37K | -$398.75K | -$577.96K | -$607.14K | -$472.71K | $235.09K | – | – | – |
| Net income per employee | -$1.17M | -$1.18M | -$1.24M | -$950.99K | -$851.04K | -$691.79K | -$780.08K | -$817.61K | -$932.77K | $129.55K | -$375.01K | -$159.20K | -$396.67K | -$576.71K | -$605.82K | -$469.40K | $221.12K | -$512.49K | -$303.69K | -$385.91K |
| Free cash flow per employee | -$794.67K | -$802.80K | -$982.86K | -$760.03K | -$756.50K | -$11.46K | -$599.53K | -$785.42K | -$763.77K | $278.63K | $43.21K | -$499.42K | -$97.18K | -$479.47K | -$582.76K | -$431.65K | $70.86K | – | – | – |
| Growth | ||||||||||||||||||||
| Revenue 1Y growth | 376.6% | 145.3% | -92.0% | 34.3% | 26.2% | 107.8% | -14.7% | 135.6% | -87.4% | 271.3% | -38.9% | 53.2% | 305.5% | 89.0% | 55.2% | -96.8% | – | – | – | – |
| Revenue 3Y CAGR | -2.4% | -36.0% | -48.7% | 52.1% | 30.8% | 61.0% | -36.8% | 3.2% | -34.2% | 51.4% | 55.9% | 127.2% | 128.3% | -54.7% | – | – | – | – | – | – |
| Revenue 5Y CAGR | 9.5% | -7.2% | -24.9% | 47.9% | -7.9% | 14.3% | -10.6% | 0.55% | 12.1% | 92.7% | 61.9% | -10.5% | – | – | – | – | – | – | – | – |
| Revenue 10Y CAGR | 11.9% | -8.9% | -13.1% | 28.7% | 33.2% | 36.0% | -10.5% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | -14.2% | -8.1% | -53.1% | -74.0% | -98.3% | 5.0% | -11.2% | 21.6% | -706.8% | 150.0% | -153.5% | 56.5% | 16.2% | 15.7% | 3.4% | -290.2% | – | – | – | – |
| EBITDA 1Y growth | -14.3% | -8.8% | -52.1% | -73.0% | -99.8% | 5.6% | -11.3% | 21.3% | -673.8% | 152.8% | -158.1% | 57.4% | 16.1% | 14.6% | 2.2% | -269.8% | – | – | – | – |
| Net income 1Y growth | -33.2% | -12.0% | -35.3% | -80.6% | -69.2% | -4.6% | -14.5% | 16.8% | -876.7% | 143.9% | -156.0% | 56.6% | 16.5% | 15.6% | 2.9% | -300.8% | 143.5% | -15.3% | 14.4% | – |
| Diluted EPS 1Y growth | -24.3% | 3.5% | -25.9% | -54.6% | -42.1% | 6.6% | -8.2% | 24.7% | -764.1% | 140.2% | -136.6% | 66.9% | 46.1% | 46.5% | 6.9% | -283.3% | – | – | – | – |
| Operating cash flow 1Y growth | -28.8% | 4.5% | -38.3% | -110.2% | -1,693.7% | 109.8% | 10.2% | 0.53% | -375.2% | 657.4% | 110.9% | -481.0% | 76.9% | 26.7% | -1.7% | -632.7% | – | – | – | – |
| Operating cash flow 5Y CAGR | – | – | – | – | – | 12.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Free cash flow 1Y growth | -33.8% | 3.8% | -33.7% | -62.4% | -8,975.1% | 97.7% | 8.4% | 2.4% | -395.7% | 718.9% | 109.4% | -456.3% | 75.4% | 27.1% | -1.6% | -676.2% | – | – | – | – |
| CapEx 1Y growth | 535.1% | 175.8% | -87.5% | -76.8% | 342.2% | 322.0% | 194.6% | -69.1% | 80.3% | 184.0% | -49.1% | 103.7% | 333.6% | -71.8% | -10.1% | -10.4% | – | – | – | – |
| CapEx 3Y CAGR | 29.8% | -56.9% | -49.6% | 63.0% | 280.2% | 56.6% | 18.0% | 16.5% | 37.6% | 43.3% | 65.0% | 35.6% | 3.2% | -39.0% | – | – | – | – | – | – |
| CapEx 5Y CAGR | 17.6% | 8.3% | 9.8% | 31.6% | 98.2% | 81.4% | 18.9% | 10.4% | 87.2% | 29.2% | 2.7% | 15.0% | – | – | – | – | – | – | – | – |
| CapEx 10Y CAGR | 46.0% | 13.5% | 10.1% | 56.9% | 60.1% | 36.5% | 16.9% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | 1.6% | 70.0% | -18.8% | 20.6% | 57.6% | 84.2% | 37.2% | -28.4% | 73.3% | 47.6% | -13.3% | 59.8% | 7.3% | 47.0% | -32.3% | – | – | – | – | – |
| Total assets 3Y CAGR | 12.0% | 18.5% | 15.6% | 51.9% | 58.5% | 21.9% | 19.4% | 22.4% | 30.4% | 26.9% | 14.1% | 36.1% | 2.2% | – | – | – | – | – | – | – |
| Total assets 5Y CAGR | 21.7% | 37.1% | 31.3% | 28.0% | 37.7% | 35.9% | 16.9% | 20.5% | 30.6% | 26.4% | 8.1% | – | – | – | – | – | – | – | – | – |
| Total assets 10Y CAGR | 28.6% | 26.6% | 25.8% | 29.3% | 31.9% | 21.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | -387.3% | 65.0% | -258.0% | -144.2% | 115.1% | 1,136.7% | -142.2% | -76.4% | 16.4% | 37.6% | -25.5% | 69.1% | -22.3% | 45.5% | -31.7% | -30.5% | 103.8% | -50.2% | -6.0% | – |
| Total equity 3Y CAGR | – | – | – | – | 111.1% | 1.1% | – | -27.7% | 6.1% | 20.1% | -0.72% | 24.1% | -8.3% | -11.6% | -1.1% | -11.0% | -1.6% | – | – | – |
| Total equity 5Y CAGR | – | – | – | – | 20.9% | 10.6% | – | -13.8% | 9.4% | 14.4% | -0.55% | -1.9% | 1.8% | -6.8% | -14.6% | – | – | – | – | – |
| Total equity 10Y CAGR | – | – | – | – | 17.6% | 4.9% | – | -6.3% | 0.95% | -1.2% | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.